Summary
Eight patients, convalescent from acute hepatitis, all negative for HBsAg, anti-HBc, anti-HA-IgM, anti-CMV and anti-EB, and all positive for non-A, non-B related antigen and/or antibody in at least one sample during the course of disease, were investigated. Their specific cell-mediated immunity was tested using the leukocyte migration inhibition test in the presence of a previously described non-A, non-B related antigen. A control group consisted of ten individuals (two normal subjects, six patients recovering from acute hepatitis B and two with autoimmune chronic active hepatitis). Leukocyte migration was inhibited by the antigen in seven of the eight patients. The test was negative in all control subjects. It is thus demonstrated that after recovery, patients with non-A, non-B viral hepatitis develop a cellular immune response specific for purified non-A, non-B related antigen. The association between the described antigen and viral hepatitis non-A, non-B can now be established not only by immunoprecipitation, but also by a cellular test.
Zusammenfassung
Mit dem Leukozytenmigration-Inhibitionstest in Anwesenheit des zuvor beschriebenen Non-A-, Non-B-assoziierten Antigens, wurde die spezifische zelluläre Immunität bei acht rekonvaleszenten Patienten geprüft, die alle negativ für HBsAg, anti-HBc, anti-HAV, IgM, anti-CMV und anti-EBV waren. Alle Patienten waren positiv im Laufe der Krankheit für Non-A-, Non-B-assoziiertes Antigen und/oder Antikörper in mindestens einer Serumprobe. Die Kontrollgruppe bestand aus zehn Individuen, zwei Gesunden, sechs Rekonvaleszenten einer akuten Hepatitis B und zwei mit chronisch aktiver Autoimmun-Hepatitis. Die Leukozytenmigration wurde in sieben von acht Patienten durch das Antigen inhibiert. Der Test war bei allen Individuen der Kontrollgruppe negativ. Dementsprechend entwickeln Patienten mit Non-A-, Non-B-Virus-Hepatitis eine spezifische zelluläre Immunantwort gegen gereinigtes Non-A-, Non-B-assoziiertes Antigen nach der Rekonvaleszenz. Die Assoziation zwischen dem beschriebenen Antigen und der Non-A-, Non-B-Virus-Hepatitis kann nun nicht nur durch Immunpräzipitation, sondern auch durch einen zellulären Test bewiesen werden.
Similar content being viewed by others
Literature
Alter, H. J., Purcell, R. H., Holland, P. V., Popper, H. Transmissible agent in non-A, non-B hepatitis. Lancet I (1978) 459–463.
Tabor, E., Gerety, R. J., Drucker, J. A., Seef, L. B., Hoofnagle, J. H., Jackson, D. R., April, M., Barker, L. F., Pineda-Tamondong, G. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet I (1978) 463–466.
Bradley, D. W., Maynard, J. E., Cook, E. H., Ebert, J. W., Gravelle, C. R., Tsiquaye, K. N., Kessler, H., Zuckerman, A. J., Miller, M. F., Ling, C., Overby, L. R. Non-A, non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies. J. Med. Virol. 6 (1980) 185–201.
Yoshizawa, H., Akahane, Y., Itoh, Y., Iwakiri, S., Kitajima, K., Morita, M., Tanaka, A., Nojiri, T., Shimizu, M., Miyakawa, Y., Mayumi, M. Virus-like particles in a plasma fraction (fibrinogen) and in the circulation of apparently healthy blood donors capable of inducing non-A, non-B hepatitis in humans and chimpanzees. Gastroenterology 79 (1980) 512–520.
Coursaget, P., Maupas, Ph., Levin, P., Barin, F. Virus-like particles associated with non-A, non-B hepatitis. Lancet II (1979) 92.
Hantz, O., Vitvitski, L., Trepo, C. Non-A, non-B hepatitis: Identification of hepatitis-B-like virus particles in serum and liver. J. Med. Virol. 5 (1980) 73–86.
Mori, Y., Ogata, S., Ata, S., Nakano, Y. Virus-like particles associated with non-A, non-B hepatitis. Lancet II (1980) 318.
Tsiquaye, K. N., Bird, R. G., Tovey, G., Wyke, R. J., Williams, R., Zuckerman, A. J. Further evidence of cellular changes associated with non-A, non-B hepatitis. J. Med. Virol. 5 (1980) 63–71.
Shirachi, R., Tateda, A., Shiraishi, H., Kikuchi, K., Ishida, N. Hepatitis “C” antigen in non-A, non-B post-transfusion hepatitis. Lancet II (1978) 853–856.
Vitvitski, L., Prince, A. M., Trepo, C., Brotman, B. Detection of virus-associated antigen in serum and liver of patients with non-A, non-B hepatitis. Lancet II (1979) 1263–1267.
Tabor, E., Mitchell, F. D., Goudeau, A. M., Gerety, R. J. Detection of an antigen-antibody system in serum associated with human non-A, non-B hepatitis. J. Med. Virol. 4 (1979) 161–169.
Arnold, W., Reiter, H. J., Martini, G. A., Meyer zum Büschenfelde, K. H. Solid phase radioimmunoassay for the determination of non-A, non-B antigen and antibody. Gastroenterology 79 (1980) 1098.
Chircu, L. V., Pezzella, M., Lacava, V., Ricci, G. Post-transfusion hepatitis: Antigen/antibody systems correlated with non-A, non-B hepatitis. J. Med. Virol. 6 (1980) 147–151.
Neurath, A. R., Stevens, C. E., Strick, N., Szmuness, W., Olesko, W. R., Harley, E. J. An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: A potential marker for non-A, non-B hepatitis. J. Gen. Virol. 48 (1980) 285–295.
Duermeyer, W., Stute, R., Hellings, J. A. An enzyme-linked immunosorbent assay for an antigen related to non-A, non-B hepatitis and its antibody: Partial characterization of the antigen and chimpanzee transmission. J. Med. Virol. 11 (1983) 11–21.
Pezzella, M., Chircu, L. V., Galli, C., Lacava, V. Non-A, non-B hepatitis: Positive and negative considerations on 138 cases. Boll. Ist sieroter Milan 62 (1983) 56–61.
Suh, D. J., Eddleston, A. L. W. F., Tsiquaye, K., White, Y., Amini, S., Zuckerman, A. J., Williams, R. Specificity of an immunoprecipitin test for non-A, non-B hepatitis. Lancet I (1981) 178–180.
Frei, P. C., Spertini, O., Lavanchy, D. Serological tests for non-A, non-B hepatitis: dead-end or reality? Clin. Immunol. Newsletter 5 (1984) 93–96.
Spertini, O., Frei, P. C. Demonstration of a single antigen-antibody system in serum samples from 26 patients with non-A, non-B viral hepatitis. Lancet II (1982) 899–903.
Frei, P. C., Erard, Ph., Zinkernagel, R. Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leukocyte migration test during and after acute B hepatitis. Biomed. Expr. 19 (1973) 379–383.
Ibrahim, A. B., Vyas, G. N., Perkins, H. A. Immune response to hepatitis B surface antigen. Infect. Immun. 11 (1975) 137–141.
Meyer zum Büschenfelde, K. H., Arnold, W., Knolle, J., Hess, G. Immunreaktionen gegenüber HBsAg, HBcAg und „e“-Antigen bei akuter Virushepatitis sowie lebergesunden und leberkranken HBsAg-Trägern. Zeitschrift für Gastroenterologie 14 (1976) 365–377.
Lee, W. M., Reed, W. D., Osman, C. G., Vahrman, J., Zuckerman, A. J., Eddleston, A. L. W. F., Williams, R. Immune responses to the hepatitis B surface antigen and liver specific lipoprotein in acute type B hepatitis. Gut 18 (1977) 250–257.
Aldershvile, J., Dietrichson, O., Hardt, F., Nielsen, J. O., Skinhöj, P. Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease. Scand. J. Gastroenterol. 12 (1977) 917–922.
Frei, P. C., Desaules, M., Krafft, T. Cell-mediated immune response to purified HBsAg in HBV infections. In:Vyas, G. N., Cohen, S. N., Schmid, R. (eds.): Viral hepatitis. Franklin Institute Press, Philadelphia 1978, p. 267.
Erard, P. Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen. Clin. Exp. Immunol. 18 (1974) 439–448.
Vallotton, J. J., Frei, P. C. Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen. Infect. Immun. 32 (1981) 432–437.
Feinstone, S. M., Hoofnagle, J. H. Non-A, maybe-B hepatitis. N. Engl. J. Med. 311 (1984) 185–189.
Tabor, E., Seef, L. B., Gerety, R. J. Chronic non-A, non-B carrier state. Transmissible agent documented in one patient over a six-year period. N. Engl. J. Med. 303 (1980) 139–143.
Kryger, P., Christoffersen, P. The Kopenhagen Hepatitis Acuta Programme: Light microscopic morphology of acute hepatitis non-A, non-B. A comparison with hepatitis type A and B. Liver 2 (1982) 200–206.
Schmid, M., Pirovino, M., Altorfer, J., Gudat, F., Bianchi, L. Acute hepatitis non-A, non-B; are there any specific light microscopic features? Liver 2 (1982) 61–67.
Bianchi, L., Gudat, F. G. Histo- and immunopathology of viral hepatitis. In:Deinhardt, F., Deinhardt, J. (eds.): Viral hepatitis: Laboratory and clinical science. Marcel Dekker Inc., New York 1983, p. 335.
Hoofnagle, J. H. Acute non-A, non-B hepatitis: clinical course and diagnosis. In:Gerety, R. J. (ed.): Non-A, non-B hepatitis. Academic Press, New York 1981, p. 23.
Duermeyer, W., Hellings, J. A., Stute, R. Characterization of DS antigen, an antigen related to non-A, non-B hepatitis. I. Physicochemical progresses. J. Virol. Meth. 6 (1983) 225–232.
Desaules, M., Frei, P. C., Libanska, J., Wuilleret, B. Lack of leucocyte migration inhibition by hepatitis B antigen and normal non-specific immunoreactivity in 25 asymptomatic carriers of this antigen. J. Infect. Dis. 134 (1976) 505–509.
Poralla, T., Hütteroth, T. H., Meyer zum Büschenfelde, K. H. Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis. Gut 25 (1984) 114–120.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nicole, A., Spertini, O., Lavanchy, D. et al. Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection. Infection 14, 13–16 (1986). https://doi.org/10.1007/BF01644803
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644803